Treatment of nocturnal asthma.
Extensive work has been done over the past decade to determine the best drug regimen for the treatment of nocturnal asthma. Much of the work has been directed at the evaluation of theophylline preparations and beta sympathomimetic agents. With a better understanding of the mechanisms causing nocturnal asthma, future therapeutic advances will be targeted at the underlying pathophysiological causes of the disorder. This article will review current treatment modalities, including those shown to have some effect as well as those that have no benefit.
Millman
R P
RP
Brown University, Pulmonary Function Laboratory, Providence, RI.
D001249:Asthma / Q000188:drug therapy / Q000628:therapy*; D002940:Circadian Rhythm; D006801:Humans; D010366:Peak Expiratory Flow Rate / Q000187:drug effects; D011175:Positive-Pressure Respiration; D013566:Sympathomimetics / Q000627:therapeutic use; D013806:Theophylline / Q000627:therapeutic use
D013566:Sympathomimetics; D013806:Theophylline